References
- Guelaud C. Les scénarios noirs du Haut Conseil de l’asurance-maladie. Le Monde, 23–12–2003.
- Gotzche P. C., Heath I., Henry D., Moynihan R. Selling sickness: the pharmaceutical industry and disease mongering. BMJ, 2002, 324: 886–891.
- Crane J., Cheshire N. Recent developments in vascular surgery. BMJ, 2003, 327: 911–915.
- Hobson R. W., Lal B. K., Chakhtoura E., Goldstein J., Haser P. B., a.o. Carotid artery stenting: analysis of data for 105 patients at high risk. J Vasc Surg, 2003, 37: 1234–9.
- Wong D. T., Ballard J. L., Killeen J. D. Carotid endarterectomy and abdominal aortic aneurysm repair are these reasonable treatments for patients over age 80 ? Am Surg, 1998, 64: 998–1001.
- Cowan J. A., Dimick J. D., Thompson B. G., Stanley J. C., Upchurch G. R. Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of speciality practice and hospital volume. J Am Coll Surg, 2002, 195: 814–21.
- Abella H. Varicose veins may be the setting of next turf war. Diagn. Imaging. Nov. 2003, 17.
- American Vascular Association. AVA Screening Program Results 2003.